Accelrys' Q1 Revenues Shoot up 66 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys reported late on Tuesday that revenues for the first quarter rose 66 percent.

The San Diego-based software solutions firm said that for the three months ended March 31, it posted $34.6 million in revenues, up from $20.8 million a year ago. Revenues for the quarter included $4 million in content revenue, related to databases that it acquired when it merged with Symyx during the summer. Accelrys had no content revenue in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.